5 A’s of smoking cessation guidelines, Nicotine replacement therapy (NRT), Bupropion, Varenicline, Tips to quit smoking and Complementary Health Approaches for Smoking Cessation are discussed in this presentation.
This document provides guidance on using the 5As method to help patients quit smoking. The 5As include: Ask about smoking status, Advise smokers to quit, Assess willingness to quit, Assist with a plan to quit, and Arrange follow-up support. Key steps involve clearly advising patients of the health risks of smoking, helping set a quit date, recommending pharmacotherapy or other assistance, and following up over the first month to prevent relapse. The overall goal is to help smokers understand smoking dangers and develop a personalized plan to quit through counseling and support.
This document discusses the health risks and consequences of smoking and provides information to help smokers quit. It notes that smoking is the leading preventable cause of death in the U.S., killing over 480,000 people per year, and that smokers die approximately 10 years earlier than non-smokers. The document lists strategies for quitting smoking like setting a quit date, changing habits, and avoiding places where smoking is common. It also outlines the substantial health and financial benefits of successfully quitting smoking long-term.
1) Smoking is an addiction caused by nicotine binding to acetylcholine receptors in the brain. This results in the release of dopamine and creates dependence.
2) Smoking cessation requires motivation, easing withdrawal symptoms, and preventing relapse as smoking is a chronic disease similar to other disorders.
3) Effective smoking cessation approaches include counseling and pharmacotherapy. Combining the two gives the best results, such as using nicotine replacements and drugs like varenicline.
This document discusses smoking cessation and tobacco use. It begins with a brief history of tobacco use and cultivation. It then covers nicotine addiction including the mechanisms of action of nicotine in the brain and body. Withdrawal symptoms and reasons for smoking are explored. The 5 A's model of smoking cessation counseling is described involving asking about smoking history, advising smokers to quit, assessing readiness, assisting with a plan, and arranging follow up. Non-pharmacological and pharmacological cessation methods are summarized.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
Part of the Addiction counselor training curriculum
Nicotine is highly addictive and the primary reason for tobacco addiction worldwide. Quitting smoking can be challenging due to nicotine withdrawal symptoms and cravings. This article discusses nicotine addiction, statistics on smoking worldwide, methods for quitting smoking such as nicotine replacement therapy and non-nicotine medications, and the long term health benefits of quitting such as reduced risk of cancer, heart disease, and other smoking-related illnesses. Overcoming nicotine addiction requires commitment to treatment and lifestyle changes but can significantly improve health outcomes.
Nicotine is a highly addictive stimulant found in tobacco. It acts on nicotinic acetylcholine receptors in the brain, releasing dopamine and causing dependence. Long term nicotine use can lead to serious health issues like cancer, cardiovascular disease, and addiction. Treatment involves nicotine replacement therapies, medications like varenicline and bupropion, and behavioral therapies to manage withdrawal symptoms and cravings. Managing nicotine dependence requires a combination of pharmacological and psychological approaches.
This document discusses methods of tobacco cessation. It begins with an introduction to tobacco use as the leading preventable cause of death globally. It then covers the history of tobacco, forms of tobacco used in India, and the health effects of tobacco use. Barriers to cessation like nicotine addiction and lack of support are examined. The document outlines goals of cessation programs like long term abstinence. It discusses behavioral management, pharmacotherapies, and counseling approaches. India's tobacco control laws aiming to restrict advertising and smoking in public are also summarized.
This document provides guidance on using the 5As method to help patients quit smoking. The 5As include: Ask about smoking status, Advise smokers to quit, Assess willingness to quit, Assist with a plan to quit, and Arrange follow-up support. Key steps involve clearly advising patients of the health risks of smoking, helping set a quit date, recommending pharmacotherapy or other assistance, and following up over the first month to prevent relapse. The overall goal is to help smokers understand smoking dangers and develop a personalized plan to quit through counseling and support.
This document discusses the health risks and consequences of smoking and provides information to help smokers quit. It notes that smoking is the leading preventable cause of death in the U.S., killing over 480,000 people per year, and that smokers die approximately 10 years earlier than non-smokers. The document lists strategies for quitting smoking like setting a quit date, changing habits, and avoiding places where smoking is common. It also outlines the substantial health and financial benefits of successfully quitting smoking long-term.
1) Smoking is an addiction caused by nicotine binding to acetylcholine receptors in the brain. This results in the release of dopamine and creates dependence.
2) Smoking cessation requires motivation, easing withdrawal symptoms, and preventing relapse as smoking is a chronic disease similar to other disorders.
3) Effective smoking cessation approaches include counseling and pharmacotherapy. Combining the two gives the best results, such as using nicotine replacements and drugs like varenicline.
This document discusses smoking cessation and tobacco use. It begins with a brief history of tobacco use and cultivation. It then covers nicotine addiction including the mechanisms of action of nicotine in the brain and body. Withdrawal symptoms and reasons for smoking are explored. The 5 A's model of smoking cessation counseling is described involving asking about smoking history, advising smokers to quit, assessing readiness, assisting with a plan, and arranging follow up. Non-pharmacological and pharmacological cessation methods are summarized.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
Part of the Addiction counselor training curriculum
Nicotine is highly addictive and the primary reason for tobacco addiction worldwide. Quitting smoking can be challenging due to nicotine withdrawal symptoms and cravings. This article discusses nicotine addiction, statistics on smoking worldwide, methods for quitting smoking such as nicotine replacement therapy and non-nicotine medications, and the long term health benefits of quitting such as reduced risk of cancer, heart disease, and other smoking-related illnesses. Overcoming nicotine addiction requires commitment to treatment and lifestyle changes but can significantly improve health outcomes.
Nicotine is a highly addictive stimulant found in tobacco. It acts on nicotinic acetylcholine receptors in the brain, releasing dopamine and causing dependence. Long term nicotine use can lead to serious health issues like cancer, cardiovascular disease, and addiction. Treatment involves nicotine replacement therapies, medications like varenicline and bupropion, and behavioral therapies to manage withdrawal symptoms and cravings. Managing nicotine dependence requires a combination of pharmacological and psychological approaches.
This document discusses methods of tobacco cessation. It begins with an introduction to tobacco use as the leading preventable cause of death globally. It then covers the history of tobacco, forms of tobacco used in India, and the health effects of tobacco use. Barriers to cessation like nicotine addiction and lack of support are examined. The document outlines goals of cessation programs like long term abstinence. It discusses behavioral management, pharmacotherapies, and counseling approaches. India's tobacco control laws aiming to restrict advertising and smoking in public are also summarized.
This document discusses smoking cessation and provides information to help people quit smoking. It discusses the harms of smoking and tactics that tobacco companies use. It also addresses common reasons and excuses for not quitting. The document outlines the physical, emotional, behavioral, social, and cognitive effects of the quitting process. It discusses stages of behavioral change and notes that many people think they can quit smoking at any time when that is often not the case. The document concludes by listing available help options for quitting smoking, including support groups, medications, health professionals, and online resources.
The document discusses the harms of smoking and benefits of smoking cessation. Smoking causes numerous diseases and premature death, while quitting smoking at any age leads to immediate and long-term health improvements. Effective smoking cessation requires a comprehensive program with public education, community programs, helping smokers quit through counseling and medications, school programs, enforcement of tobacco regulations, and ongoing monitoring and evaluation.
This document discusses smoking prevention and cessation. It notes that smoking greatly increases cancer risks and is a leading cause of cancer deaths. Nearly 4,000 children begin smoking daily in the US. Smoking is linked to numerous health conditions like heart disease and COPD. Quitting smoking promotes health by improving tolerance and reducing wrinkles. Prevention should begin in childhood and adolescence. Cessation requires an individualized multidimensional program using information, behavior modification, medications, support groups and follow up to help people quit smoking.
This is a short presentation to tell about word no tobacco day. this presentation also tells tobacco and its harmful effects, status in india, government act for its use, sale and distribution
This document discusses smoking cessation and nicotine addiction. It covers physiological and psychological reasons for smoking, effects of nicotine and withdrawal symptoms. It describes nicotine as highly addictive due to its effects on the brain's reward pathway. A combination of behavioral support and proven pharmacotherapy like nicotine replacement therapy, bupropion, and varenicline is recommended for successful smoking cessation. Quitting provides major health benefits but is challenging due to nicotine addiction in the brain and body.
Tobacco use is the largest preventable cause of illness and death globally. Since the 1950s and 1980s, tobacco use has been the leading cause of cancer deaths in men and women respectively. If current smoking patterns continue, tobacco is estimated to cause about 10 million deaths annually by 2030. Currently, about 1 in 5 adults smoke worldwide and 4 in 10 nonsmokers are exposed to secondhand smoke. Smoking rates tend to be higher among those with lower education levels. Tobacco can be consumed through smoking methods like cigarettes, cigars, and hookah, as well as smokeless forms like chewing tobacco and snuff.
1. Tobacco use is the leading preventable cause of death worldwide, killing over 6 million people annually. This number is projected to rise to over 8 million deaths by 2030.
2. Cigarettes contain over 4,800 chemicals, including 69 that cause cancer. Smoking causes diseases like lung cancer, emphysema, and heart disease and reduces life expectancy by 10-14 years on average.
3. Secondhand smoke kills over 600,000 non-smokers annually through diseases like lung cancer and heart disease. Children exposed to secondhand smoke are also at risk for health issues.
This document discusses self-medication and provides guidance on how to do it safely. It defines self-medication as using medicines without consulting a doctor to treat perceived or real health issues. While self-medication can help relieve costs, it may reduce monitoring and transfer financial burden to patients. The document advises consulting a pharmacist before self-medicating and provides examples of when self-medication may not be appropriate. It emphasizes the importance of responsible self-medication by being informed about proper use, dosage, and side effects of medicines.
This document provides an overview of smoking cessation. It begins with an introduction discussing the negative health impacts of smoking and statistics on smoking rates. It then covers the chemical components in cigarettes and negative effects of smoking on various parts of the body. Benefits of smoking cessation are outlined. The document also summarizes several research studies on smoking cessation methods and their effectiveness, including enhanced motivational interviewing versus brief advice, nicotine replacement therapy, and a randomized trial of nicotine replacement therapy patches in pregnancy. Barriers to smoking cessation and electronic cigarettes are also discussed.
Dr. Priyanka Kumawat presented on smoking cessation treatments. Key points:
1) Quitting smoking reduces health risks but is difficult due to nicotine addiction. Over 1 billion people smoke worldwide and smoking causes many cancers and pulmonary/cardiovascular diseases.
2) FDA-approved smoking cessation treatments include nicotine replacement therapies, bupropion, and varenicline. Emerging treatments include e-cigarettes, vaccines, and drugs targeting nicotine receptors or withdrawal symptoms.
3) All smokers trying to quit should be offered medication. Higher doses of nicotine replacements may help highly dependent smokers. Second-line drugs like clonidine may help those unable to use first-line
2008 Smoking Cessation Health Promotion Power point filled with history of glamour movie stars who died from smoking, medical/military history, statistics and facts, myth/truth, perception/reality, Nurses' role, Health effects of smoking, Helps to quit: web sites, medications: Zyban, Chantix, Addiction notations. Factual/non-fiction.
14 slides plus 2 reference slides. 2008.
It gives insight into why tobacco smoking is harful and what strategies one should adpot to quit smoking. Some interesting snapshots makes the point clear to all
Steps of Smoking Cessation Badr Bin Himd.pptxFayzaRayes
This document outlines the steps for smoking cessation counseling using the 5As technique. It begins by establishing smoking as a major health problem in Saudi Arabia, with prevalence rates ranging from 2.4-52.3%. The 5As technique involves asking about tobacco use, advising the patient to quit, assessing willingness to quit, assisting with a plan to quit, and arranging follow-up support. Counseling should be tailored based on a patient's stage of change and use motivational techniques. Pharmacotherapy and follow-up are important to prevent relapse among those trying to quit. The 5As approach is effective when fully implemented in clinical settings.
Tobacco contains the highly addictive drug nicotine and can be consumed through smoking, chewing, dipping, or sniffing in products like cigarettes, gutkha, and snuff. Smoking cigarettes exposes a person to over 4000 toxic chemicals and 60 carcinogens and significantly increases the risks of various cancers, heart disease, lung disease, and other health issues. Tobacco use is directly linked to many forms of cancer as well as other serious diseases.
The document summarizes properties and uses of benzodiazepines. It discusses how benzodiazepines act by potentiating GABA, have sedative, anxiolytic and anticonvulsant properties, and replaced barbiturates due to a safer profile. It describes the classification, pharmacokinetics, mechanisms of action, and uses of various benzodiazepines like diazepam, midazolam and lorazepam in conditions like anxiety, insomnia, muscle relaxation and as anticonvulsants. It also notes potential adverse effects with high doses or interactions.
Tobacco use is the leading preventable cause of death in the United States, killing over 400,000 Americans each year from diseases like lung cancer, heart disease, and stroke. Tobacco contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, ammonia, and arsenic. While tobacco companies promote myths that some tobacco products like cigars, hookahs, and cloves are safer, all tobacco products are addictive and cause serious health issues. Quitting smoking can significantly reduce health risks, and medications and support groups can help in quitting.
Tobacco . Its definition, available forms , fatal dose , contents , pathophysiology , pharmacokinetics and toxicology. Diagnosis and treatment of toxicity.
The document discusses nicotine addiction and pharmacotherapy options for smoking cessation. It begins by explaining how nicotine acts on the brain's reward pathway similarly to drugs like heroin and cocaine. Nicotine rapidly increases dopamine release in the nucleus accumbens, reinforcing the behavior. Pharmacotherapies like nicotine replacement therapy, bupropion, and varenicline can help relieve withdrawal symptoms and cravings by interacting with nicotinic receptors. NRT is considered low risk and safer than smoking, delivering nicotine without other harmful chemicals. Combining medication with behavioral counseling improves quit rates.
Management of Opioid Analgesic OverdoseSun Yai-Cheng
This document summarizes the management of opioid analgesic overdoses. It notes that opioid overdoses can have life-threatening effects on multiple organ systems. The duration of action varies between opioid formulations and an overdose can prolong intoxication. Prescriptions for opioid analgesics in the US increased 700% from 1997-2007. Opioid overdoses lead to over 27,500 health care facility admissions in 2010. Clinical signs of overdose include respiratory depression, apnea, miosis, and stupor. Naloxone is the antidote and works by reversing opioid receptor activity but has a shorter duration than many opioids. Higher and repeated naloxone doses may be needed for long-acting opioids like
This document discusses the dangers of tobacco use and provides information about World No Tobacco Day on May 31st. It notes that tobacco is the single largest preventable cause of death and disability globally. The document then provides details on the history and spread of tobacco use, the various forms of smoking and smokeless tobacco products consumed in India, health effects of tobacco including increased cancer and heart disease risks, and statistics on tobacco use and related deaths in India.
This document summarizes a seminar presentation on tobacco cessation. It discusses the large number of tobacco users in India and the health impacts of tobacco use. It outlines regulatory, service-based, and educational approaches to tobacco control and the role of dentists in counseling patients. The 5 A's model for tobacco cessation counseling is described. Nicotine replacement therapies and other pharmacological aids are discussed. The presentation emphasizes the importance of dentists' involvement in tobacco control through counseling, advocacy, and community education efforts.
Smoking rates in Australia remain high, with 30% of men and 27% of women smoking on average 18 cigarettes per day. By age 15, 25% of boys and 28% of girls are regular smokers. Smoking causes numerous health problems such as cancer, heart disease, and strokes. Anti-smoking campaigns in Australia use graphic images and videos to raise awareness of smoking's health risks and negative consequences. The document provides statistics on smoking prevalence in Australia and discusses various anti-smoking initiatives and campaigns.
This document discusses smoking cessation and provides information to help people quit smoking. It discusses the harms of smoking and tactics that tobacco companies use. It also addresses common reasons and excuses for not quitting. The document outlines the physical, emotional, behavioral, social, and cognitive effects of the quitting process. It discusses stages of behavioral change and notes that many people think they can quit smoking at any time when that is often not the case. The document concludes by listing available help options for quitting smoking, including support groups, medications, health professionals, and online resources.
The document discusses the harms of smoking and benefits of smoking cessation. Smoking causes numerous diseases and premature death, while quitting smoking at any age leads to immediate and long-term health improvements. Effective smoking cessation requires a comprehensive program with public education, community programs, helping smokers quit through counseling and medications, school programs, enforcement of tobacco regulations, and ongoing monitoring and evaluation.
This document discusses smoking prevention and cessation. It notes that smoking greatly increases cancer risks and is a leading cause of cancer deaths. Nearly 4,000 children begin smoking daily in the US. Smoking is linked to numerous health conditions like heart disease and COPD. Quitting smoking promotes health by improving tolerance and reducing wrinkles. Prevention should begin in childhood and adolescence. Cessation requires an individualized multidimensional program using information, behavior modification, medications, support groups and follow up to help people quit smoking.
This is a short presentation to tell about word no tobacco day. this presentation also tells tobacco and its harmful effects, status in india, government act for its use, sale and distribution
This document discusses smoking cessation and nicotine addiction. It covers physiological and psychological reasons for smoking, effects of nicotine and withdrawal symptoms. It describes nicotine as highly addictive due to its effects on the brain's reward pathway. A combination of behavioral support and proven pharmacotherapy like nicotine replacement therapy, bupropion, and varenicline is recommended for successful smoking cessation. Quitting provides major health benefits but is challenging due to nicotine addiction in the brain and body.
Tobacco use is the largest preventable cause of illness and death globally. Since the 1950s and 1980s, tobacco use has been the leading cause of cancer deaths in men and women respectively. If current smoking patterns continue, tobacco is estimated to cause about 10 million deaths annually by 2030. Currently, about 1 in 5 adults smoke worldwide and 4 in 10 nonsmokers are exposed to secondhand smoke. Smoking rates tend to be higher among those with lower education levels. Tobacco can be consumed through smoking methods like cigarettes, cigars, and hookah, as well as smokeless forms like chewing tobacco and snuff.
1. Tobacco use is the leading preventable cause of death worldwide, killing over 6 million people annually. This number is projected to rise to over 8 million deaths by 2030.
2. Cigarettes contain over 4,800 chemicals, including 69 that cause cancer. Smoking causes diseases like lung cancer, emphysema, and heart disease and reduces life expectancy by 10-14 years on average.
3. Secondhand smoke kills over 600,000 non-smokers annually through diseases like lung cancer and heart disease. Children exposed to secondhand smoke are also at risk for health issues.
This document discusses self-medication and provides guidance on how to do it safely. It defines self-medication as using medicines without consulting a doctor to treat perceived or real health issues. While self-medication can help relieve costs, it may reduce monitoring and transfer financial burden to patients. The document advises consulting a pharmacist before self-medicating and provides examples of when self-medication may not be appropriate. It emphasizes the importance of responsible self-medication by being informed about proper use, dosage, and side effects of medicines.
This document provides an overview of smoking cessation. It begins with an introduction discussing the negative health impacts of smoking and statistics on smoking rates. It then covers the chemical components in cigarettes and negative effects of smoking on various parts of the body. Benefits of smoking cessation are outlined. The document also summarizes several research studies on smoking cessation methods and their effectiveness, including enhanced motivational interviewing versus brief advice, nicotine replacement therapy, and a randomized trial of nicotine replacement therapy patches in pregnancy. Barriers to smoking cessation and electronic cigarettes are also discussed.
Dr. Priyanka Kumawat presented on smoking cessation treatments. Key points:
1) Quitting smoking reduces health risks but is difficult due to nicotine addiction. Over 1 billion people smoke worldwide and smoking causes many cancers and pulmonary/cardiovascular diseases.
2) FDA-approved smoking cessation treatments include nicotine replacement therapies, bupropion, and varenicline. Emerging treatments include e-cigarettes, vaccines, and drugs targeting nicotine receptors or withdrawal symptoms.
3) All smokers trying to quit should be offered medication. Higher doses of nicotine replacements may help highly dependent smokers. Second-line drugs like clonidine may help those unable to use first-line
2008 Smoking Cessation Health Promotion Power point filled with history of glamour movie stars who died from smoking, medical/military history, statistics and facts, myth/truth, perception/reality, Nurses' role, Health effects of smoking, Helps to quit: web sites, medications: Zyban, Chantix, Addiction notations. Factual/non-fiction.
14 slides plus 2 reference slides. 2008.
It gives insight into why tobacco smoking is harful and what strategies one should adpot to quit smoking. Some interesting snapshots makes the point clear to all
Steps of Smoking Cessation Badr Bin Himd.pptxFayzaRayes
This document outlines the steps for smoking cessation counseling using the 5As technique. It begins by establishing smoking as a major health problem in Saudi Arabia, with prevalence rates ranging from 2.4-52.3%. The 5As technique involves asking about tobacco use, advising the patient to quit, assessing willingness to quit, assisting with a plan to quit, and arranging follow-up support. Counseling should be tailored based on a patient's stage of change and use motivational techniques. Pharmacotherapy and follow-up are important to prevent relapse among those trying to quit. The 5As approach is effective when fully implemented in clinical settings.
Tobacco contains the highly addictive drug nicotine and can be consumed through smoking, chewing, dipping, or sniffing in products like cigarettes, gutkha, and snuff. Smoking cigarettes exposes a person to over 4000 toxic chemicals and 60 carcinogens and significantly increases the risks of various cancers, heart disease, lung disease, and other health issues. Tobacco use is directly linked to many forms of cancer as well as other serious diseases.
The document summarizes properties and uses of benzodiazepines. It discusses how benzodiazepines act by potentiating GABA, have sedative, anxiolytic and anticonvulsant properties, and replaced barbiturates due to a safer profile. It describes the classification, pharmacokinetics, mechanisms of action, and uses of various benzodiazepines like diazepam, midazolam and lorazepam in conditions like anxiety, insomnia, muscle relaxation and as anticonvulsants. It also notes potential adverse effects with high doses or interactions.
Tobacco use is the leading preventable cause of death in the United States, killing over 400,000 Americans each year from diseases like lung cancer, heart disease, and stroke. Tobacco contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, ammonia, and arsenic. While tobacco companies promote myths that some tobacco products like cigars, hookahs, and cloves are safer, all tobacco products are addictive and cause serious health issues. Quitting smoking can significantly reduce health risks, and medications and support groups can help in quitting.
Tobacco . Its definition, available forms , fatal dose , contents , pathophysiology , pharmacokinetics and toxicology. Diagnosis and treatment of toxicity.
The document discusses nicotine addiction and pharmacotherapy options for smoking cessation. It begins by explaining how nicotine acts on the brain's reward pathway similarly to drugs like heroin and cocaine. Nicotine rapidly increases dopamine release in the nucleus accumbens, reinforcing the behavior. Pharmacotherapies like nicotine replacement therapy, bupropion, and varenicline can help relieve withdrawal symptoms and cravings by interacting with nicotinic receptors. NRT is considered low risk and safer than smoking, delivering nicotine without other harmful chemicals. Combining medication with behavioral counseling improves quit rates.
Management of Opioid Analgesic OverdoseSun Yai-Cheng
This document summarizes the management of opioid analgesic overdoses. It notes that opioid overdoses can have life-threatening effects on multiple organ systems. The duration of action varies between opioid formulations and an overdose can prolong intoxication. Prescriptions for opioid analgesics in the US increased 700% from 1997-2007. Opioid overdoses lead to over 27,500 health care facility admissions in 2010. Clinical signs of overdose include respiratory depression, apnea, miosis, and stupor. Naloxone is the antidote and works by reversing opioid receptor activity but has a shorter duration than many opioids. Higher and repeated naloxone doses may be needed for long-acting opioids like
This document discusses the dangers of tobacco use and provides information about World No Tobacco Day on May 31st. It notes that tobacco is the single largest preventable cause of death and disability globally. The document then provides details on the history and spread of tobacco use, the various forms of smoking and smokeless tobacco products consumed in India, health effects of tobacco including increased cancer and heart disease risks, and statistics on tobacco use and related deaths in India.
This document summarizes a seminar presentation on tobacco cessation. It discusses the large number of tobacco users in India and the health impacts of tobacco use. It outlines regulatory, service-based, and educational approaches to tobacco control and the role of dentists in counseling patients. The 5 A's model for tobacco cessation counseling is described. Nicotine replacement therapies and other pharmacological aids are discussed. The presentation emphasizes the importance of dentists' involvement in tobacco control through counseling, advocacy, and community education efforts.
Smoking rates in Australia remain high, with 30% of men and 27% of women smoking on average 18 cigarettes per day. By age 15, 25% of boys and 28% of girls are regular smokers. Smoking causes numerous health problems such as cancer, heart disease, and strokes. Anti-smoking campaigns in Australia use graphic images and videos to raise awareness of smoking's health risks and negative consequences. The document provides statistics on smoking prevalence in Australia and discusses various anti-smoking initiatives and campaigns.
The document discusses the health effects and consequences of smoking. It covers causes of smoking like peer pressure, reasons for quitting like health and cost, and possible solutions like nicotine gum and increased cigarette prices. Health risks of smoking include diseases and reduced life expectancy. The document provides statistics on smoking prevalence and deaths worldwide.
Smoking has been widespread in Britain since the 16th century, though its health risks were not firmly established until the 1950s. Currently, about 12 million British adults smoke, with rates highest among younger people and those from manual socioeconomic groups. Smoking causes over 100,000 deaths per year in the UK due to increased risks of cancer, heart disease, and respiratory illness. While some believe there are benefits to smoking like stress relief, evidence shows smokers have higher stress levels and that smoking provides only temporary relief through addiction, not actual stress reduction.
This document summarizes the history of cigarettes and their harmful effects. It notes that cigarettes were first mass produced in the late 1800s and contained over 4000 chemicals, including 60 carcinogens. The summary describes some of the major health risks of smoking such as heart disease, cancer, and reduced lung function. It also mentions that smoking can harm fetal development and increase risks during pregnancy. The document aims to inform people about the long history of cigarette use and their significant health consequences.
Smoking refers to inhaling tobacco from cigarettes, cigars or pipes. It can lead to serious health issues like heart disease, cancer and strokes. While some teenagers are curious or want attention, smoking is not good for one's health or athletic performance. It is difficult to quit smoking once started. The document provides steps for quitting smoking and advice for saying no to peer pressure to smoke.
This is an informative presentation, providing an introduction to smoking cessation. Included: photos of smoking vs. non-smoking twins, healthy / disease free lungs vs. a smoker's lungs, video clips on the effects of smoking, including unseen dangers of smoking. Click on various images throughout the presentation for links to videos and websites. For more information on quitting smoking, please visit www.lung.org, or www.smokefree.gov.
This document provides information about the negative health effects of smoking through statistics and facts. It notes that over 1.3 billion people worldwide smoke, resulting in nearly 5 million deaths per year globally from tobacco-related illnesses. In India specifically, it is estimated that 635,000 people die from tobacco each year, with smoking causing cancers, heart disease, and other serious health issues. The document also outlines the over 4,000 chemicals found in cigarette smoke, many of which are carcinogenic, and explains the increased risks of various cancers and diseases that smoking poses. It provides advice on ways to quit smoking and the health benefits of doing so.
Discover the effects of smoking on your finances,society,health,environment and unborn baby.These slides will open your eyes to the harmful effects of tobacco,so,much so that you won't want to touch it again.
Complementary and alternative therapies for Coronary Heart Disease (CHD)Naina Mohamed, PhD
Dietary supplements used to treat Coronary Heart Disease (CHD) include Omega 3 fatty acids, Vitamin C, Vitamin E, Fiber and Coenzyme Q10. And the Mind-Body approaches to treat CHD include Chelation therapy, Meditation, Acupuncture, Reflexology and Tai chi.
Complementary and alternative therapies for hypertensionNaina Mohamed, PhD
To treat hypertension many CAM approaches are useful including Mind and Body Practices such as Dynamic Aerobic (Endurance) Exercise, Dynamic Resistance Exercise, Device-Guided Slow Breathing, Transcendental Meditation (TM), Biofeedback Techniques and Acupuncture, Herbal Supplements such as Garlic, Black cumin, Cinnamon, Flaxseed, Sour Tea, Ginger, Cardamom, Green Tea, Sweet basil, Celery, Ginseng, Saffron, Goldthread, Oats, Chinese hawthorn, Carrot, Tomato, Pomegranate, Radish and Sesame and Dietary Supplements like Coenzyme Q10, Omega 3 FAs, Melatonin and Vitamin D.
The health benefits of Smoking Cessation such as Better sex, Improved fertility, Younger looking skin, Whiter teeth, Better breathing, Longer life, Less stress, Improved smell and taste, More energy and Healthier loved ones are discussed in this presentation.
Negative effects of smoking on babies like Low birth weight, Premature delivery, Stillbirth, Increased risk of Asthma or SIDS, Elevated risk of congenital heart defects and Lifelong effects on baby's brain are discussed in this presentation.
Negative effects of smoking on mothers such as difficulty getting pregnant, Placental abruption, Placenta previa, Premature rupture of membranes and Ectopic pregnancy are also dealt in this presentation.
This document discusses the negative health effects of smoking such as shortening one's life, leading to impotence, and killing the smoker. It encourages stopping smoking by pointing out how it damages one's future health and well-being. The document takes a strong stance against smoking by listing its downsides and urging the reader to say no and stop smoking.
Pharmacoepidemiology is the study of effects of drugs in large numbers of people.
Epidemiologic Study Designs, Reasons to perform Pharmacoepidemiology studies, Users of pharmacoepidemiology and Role of Pharmacists & other Public Health Practitioners in Pharmacoepidemiology are discussed in this presentation.
Smoking has significant negative effects on periodontal health and outcomes of periodontal therapy. According to the document, smoking is a major risk factor for periodontitis, with smokers being 2-4 times more likely to develop periodontitis than non-smokers. Smoking reduces blood flow and oxygen to the gingiva, inhibits immune response, increases periodontal pathogens, and reduces fibroblast function, all of which promote periodontal disease and make treatment more challenging. The document examines in detail the epidemiological evidence linking smoking to periodontal disease as well as the mechanisms by which smoking damages periodontal tissues.
Tobacco contains over 4000 chemicals, including 63 known carcinogens. Smoking is highly addictive due to nicotine and kills more people worldwide than AIDS, automobile accidents, alcohol, fires, homicides, suicides, and drug overdoses combined. Starting at a young age puts one at high risk of lifelong addiction and negative health consequences, including various cancers and premature death. Secondhand smoke also endangers others, especially infants and children. Quitting smoking has significant health benefits.
This document provides information about HIV/AIDS, including what it is, how it is transmitted, symptoms, and prevention. It defines HIV as the virus that causes AIDS by weakening the immune system. AIDS is the late stage of HIV infection when the immune system is severely damaged. HIV can be transmitted via blood, semen, vaginal fluids, breast milk, and other bodily fluids through sexual contact, needle sharing, or from mother to child during pregnancy, birth or breastfeeding. Prevention methods include safe sex practices and not sharing needles.
This presentation provides an overview of HIV and AIDS. It defines HIV as a virus that attacks the immune system and destroys the body's ability to fight infections and diseases. It is transmitted through certain body fluids like blood, semen, vaginal fluids, and breast milk. The presentation details how HIV infects and replicates within immune cells called CD4 cells. It explains the stages of HIV infection from the initial window period to the development of AIDS when the immune system is severely compromised. Treatment options are discussed as well as strategies for prevention.
This document provides 10 ways to stop smoking without nicotine replacement therapy (NRT). It discusses using hypnosis, self-hypnosis, acupuncture, behavioral therapy, stop smoking groups, and quitting cold turkey. Natural alternatives to NRT mentioned include lobelia, cayenne pepper, vitamins C and antioxidants. The document emphasizes having strong willpower and identifying reasons to quit as keys to success without NRT.
The presentation by Dr.M.S.Chandragupta, Chief Dental Surgeon, Dr. Gupta's Dental Specialities Centre, deals with Tobacco Cessation Methodologies.
Tobacco is the number one killer in the world and kills around 9 lakh people annually in India alone. The victims succumb to tobacco in the most productive years of their life. To curb this issue the World Health Organization has brought out a public health legal treaty called ‘Frame Work Convention on Tobacco Control (FCTC)’ which more than 176 countries have signed and ratified the same. India has signed in the year 2005 and initiated measures to bring down the demand and supply of tobacco in India as mandated by the FCTC. India has the second highest number of tobacco users in the world, at an alarming number of 274 million users (GATS Report, 2010) and it is high time we act together to make India Tobacco Free for a healthier and wealthier tomorrow
This document discusses inhalant use disorder and nicotine abuse. It defines inhalant use disorder as the deliberate inhalation of volatile substances like glue, gasoline and cleaning fluids to induce psychoactive effects. Commonly abused inhalants include solvents, aerosols, gases and nitrites. Nicotine abuse is defined as the use of nicotine, found in tobacco, leading to addiction. Symptoms of inhalant and nicotine intoxication and withdrawal are described. The management of these disorders involves pharmacological and psychosocial interventions. Nurses play an important role in education, monitoring, administration of treatment and supporting recovery.
This document discusses the health effects of smoking and provides information on smoking cessation. Some key points:
1) Smoking significantly increases the risk of developing respiratory diseases and cancer, and over half of respiratory disease deaths are due to smoking. The risks diminish rapidly after quitting.
2) Nicotine replacement therapies like patches, gum, and lozenges can help reduce withdrawal symptoms and increase success rates for quitting. Bupropion is also used as a non-nicotine oral therapy.
3) Electronic nicotine delivery systems (ENDS) like e-cigarettes are increasingly popular but their long-term safety is still unknown. While they may contain fewer toxicants than cigarettes, health risks may
Nicotine is a highly addictive substance found in tobacco plants. It acts as both a stimulant and sedative, increasing heart rate, blood pressure, and the release of adrenaline. While nicotine can improve memory and concentration in the short term, long-term use leads to many negative health effects. Nicotine poisoning can occur from overdose and causes stimulant effects initially, followed by depressant effects like low blood pressure and breathing difficulties. Treatment focuses on medication, behavioral support, and medical care in severe cases. Prevention emphasizes avoiding nicotine products and safely storing them away from children and pets.
Lifestyle and health : Drug effects , cause and how to stop!SerenaLuu
We have heard much of nicotine, especially when we speak about the effects of tobacco to human health. Quit the essence is to relieve the addiction of nicotine acting on the user. However just a few people clearly understand what is nicotine, what is its harm and does it totally harm ? So today this presentation will help you to know!
This document summarizes information on tobacco use and smoking cessation. It discusses the health risks of smoking like increased risk of cancer, heart disease and stroke. It also outlines nicotine withdrawal symptoms and approaches to smoking cessation like the 5 A's model and use of medications like nicotine replacement therapy, Bupropion and Varenicline. Statistics on smoking prevalence in Malaysia from several national health surveys are presented.
This document provides information on tobacco dependence treatment. It begins with objectives and an introduction noting the global impact of tobacco use. It then describes various types of tobacco products and their significant health side effects. Signs and symptoms of nicotine dependence are outlined using the Fagerstrom Test. The benefits of quitting and roles of medical staff in treatment are discussed. Treatment methods covered include counseling, nicotine replacement therapy, medications, and support groups. Nicotine withdrawal symptoms and specifics of nicotine patches, gum, and other replacement products are also summarized.
Ways to Stop Smoking discusses various methods to quit smoking including going "cold turkey" without treatment, nicotine replacement therapy using gum, patches, and other nicotine delivery methods, electronic cigarettes, psychology-based approaches like education and group therapy, and hypnosis. Smoking is highly dangerous and the leading cause of preventable death, so finding an effective method to quit is important for health and longevity.
This document discusses guidelines for smoking cessation interventions and treatment. It outlines recommendations from the WHO and US Public Health Service on promoting non-smoking as the norm, prohibiting tobacco promotion, and reducing tobacco industries. The goals of smoking cessation treatment are achieving long-term abstinence, offering treatment to all tobacco users, and consistently identifying and treating tobacco use. Dental professionals can play a key role in educating patients and the community about the harms of tobacco and helping to enroll them in cessation programs. Assessment tools like the Fagerstrom Test and stages of change model are also discussed to guide treatment and counseling approaches. A variety of nicotine replacement therapies and non-nicotine medications are described for treating nic
This document discusses tobacco-related disorders and smoking cessation. It begins with a vignette of a patient with schizophrenia who smokes and has made multiple unsuccessful attempts to quit. It then outlines the epidemiology of tobacco use, the pathophysiological effects of nicotine, clinical features of tobacco dependence, and diagnosis and treatment of tobacco use disorder. The document emphasizes the high rates of tobacco use among psychiatric patients and the need for psychiatrists to address smoking cessation.
This document outlines strategies for smoking cessation. It begins by defining smoking and listing the common constituents in tobacco smoke. It then discusses the various forms of smoking and their health effects, both oral and general. The stages of change model for smoking cessation is introduced. Various cessation approaches like pharmacotherapy, counseling, and alternatives to smoking are described. The 5As framework for helping patients quit is covered in detail. Motivational interviewing techniques and coping strategies while quitting are also summarized.
1. The document provides information on treating tobacco use and dependence, including psycho-behavioral therapy and pharmacotherapy like nicotine replacement therapy and antidepressants.
2. It outlines the 5 A's approach to counseling patients - Ask, Advise, Assess, Assist, and Arrange follow-up. This includes identifying tobacco users, advising them to quit, developing a cessation plan, and scheduling follow-ups.
3. Actions to address tobacco use include public education, advocacy, and regulatory approaches at community, state, and national levels to reduce tobacco-related harms.
This document discusses the biological basis of tobacco addiction and implications for treatment. It begins by explaining why people begin abusing drugs, such as for pleasure, stress relief, or peer pressure. It then defines addiction and dependence, outlining the diagnostic criteria. The document discusses how nicotine acts in the brain through acetylcholine receptors to stimulate the reward pathway. Genetic and conditioning factors that contribute to addiction are also reviewed. The text closes by summarizing withdrawal symptoms and different pharmacological treatments used to aid smoking cessation.
Smoking causes numerous health risks and is highly addictive. Once someone becomes a smoker, they face increased risks of cancer, respiratory diseases, cardiovascular disease, fertility issues, and more. Symptoms of smoking include coughing, shortness of breath, fatigue, and poor circulation. Quitting smoking is difficult due to withdrawal symptoms like cravings, but medical help and social support can aid in successfully quitting for good.
Using the commit lozenge to stop smokingJane Allen
The document discusses using the Commit Lozenge to stop smoking. It provides information on how Commit Lozenges work to curb nicotine cravings and help people quit smoking. The lozenges release nicotine gradually to help manage withdrawal symptoms without smoking. Instructions are given on using Commit Lozenges correctly over 12 weeks to gradually wean off nicotine addiction. Research studies have found the lozenges to be an effective smoking cessation aid when used as directed.
The document discusses 5 different ways to quit smoking: water therapy, nicotine replacement therapy, cold turkey, hypnotherapy, and varenicline. Water therapy involves drinking water to flush toxins from the body and reduce cravings. Nicotine replacement therapy provides nicotine through patches, gums, or inhalers to satisfy physical dependency. Cold turkey involves quitting abruptly using willpower alone. Hypnotherapy uses hypnosis to help smokers quit. Varenicline blocks nicotine receptors in the brain and has a high success rate. The document encourages smokers to approach quitting positively and rely on methods like these to overcome addiction.
1) Cigarette smoking accounts for 6 million deaths annually worldwide mainly due to cancer, heart disease and smoking related lung disease. Quitting smoking at any age has major health benefits and reduces risks of diseases like coronary heart disease and lung cancer.
2) Medications like nicotine replacement therapy, varenicline, and bupropion can help with quitting smoking, as can behavioral counseling to develop coping skills.
3) Quitting smoking is difficult but has far greater benefits than risks like weight gain or withdrawal symptoms. Relapse is common but should not be seen as failure, and repeated attempts to quit can lead to long-term success.
Smoking has significant negative effects on periodontal health and outcomes of periodontal treatment. It increases the prevalence and severity of periodontal disease, affects the pathogenesis by altering the microbiome and inflammatory response, and decreases the response to nonsurgical and surgical periodontal therapies. Dentists play an important role in educating patients on the harms of smoking and counseling those who use tobacco on methods for cessation using pharmacotherapy and behavioral support. Smoking cessation improves periodontal treatment outcomes by allowing the periodontium to recover.
• Vorapoxar may interact with CYP3A4 enzyme inhibitors such as Ketoconazole, Itraconazole, Posaconazole, Clarithromycin, Nefazodone, Ritonavir, etc.
• Vorapoxar may also interact with CYP3A4 enzyme inducers like Rifampin.
• Cilostazol is a selective inhibitor of phosphodiesterase 3 (PDE3) and it is an antiplatelet drug and a vasodilator.
• Cilostazol can interact with Omeprazole, Fluoxetine, Fluvoxamine, Aspirin, Ticlopidine, Ticagrelor, Nefazodone, Azole antifungals, Idelalisib, Amiodarone, Cobicistat, Piperaquine and Ginkgo.
This document discusses drug interactions of glycoprotein IIB/IIIA inhibitors, which are intravenous antplatelet medications used to treat acute coronary syndromes and during percutaneous coronary intervention. It notes that combining glycoprotein IIB/IIIA inhibitors with other antplatelets or supplements like ginkgo can increase the risk of bleeding due to additive effects on platelet inhibition. Specifically, it advises avoiding concurrent use of different glycoprotein IIB/IIIA inhibitors or combining different types without monitoring for bleeding. The conclusion emphasizes minimizing drug interactions through education of healthcare providers and patients.
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Naina Mohamed, PhD
Dipyridamole is used as an Antiplatelet drug by inhibiting the reuptake of adenosine. Dipyridamole can interact with many drugs including ADP blockers (Clopidogrel, Prasugrel, Ticlopidine, Ticagrelor, etc), Glycoprotein IIB/IIIA inhibitors (Abciximab, Tirofiban, etc.), Fibrinolytics (Reteplase, Tenecteplase, Streptokinase, etc.), Adenosine, Treprostinil, Sulfinpyrazone, Regadenoson, Distigmine and Ginkgo.
Drug Interactions of ADP receptor Blockers (Antiplatelets)Naina Mohamed, PhD
· ADP receptor Blockers (Antiplatelets) include Thienopyridines (Clopidogrel, Prasugrel, Ticlopidine) and Non-Thienopyridines (Ticagrelor, Cangrelor, Elinogrel ).
· The risk of adverse effects could be reduced by healthcare professionals through the screening, education, and follow up on suspected drug interactions.
Aspirin is an antiplatelet drug and it produces antiplatelet activity in lower doses (75-100 mg daily), while Higher dose of Aspirin (Up to 3600 mg daily in divided doses) is required for it’s analgesic effects.
§ Islamic fasting is similar to Alternate Day Fasting (ADF), since the feast and fast periods of Islamic fasting lasts 12 hours in average.
§ Though Islamic fasting is associated with some adverse effects, there was no detrimental effects on health attributed directly to them, in health individuals. And the adverse effects of fasting could be minimized very easily by following the preventive measures.
§ The chronic patients with Diabetes, Coronary Artery Disease (CAD), Cancer, Ulcer, Urolithiasis, Chronic Kidney Disease (CKD), etc. should consult the healthcare professionals before observing Fasting.
§ Moreover, Islam exempts the Sick, Travelers and Pregnant, Breast Feeding and Menstruating women from fasting.
§ Islamic Fasting can be good for health if it's done correctly.
Clinically Important Drug Interactions of FibrinolyticsNaina Mohamed, PhD
• It is Contraindicated to use Fibrinolytics and Defibrotide concomitantly.
• Drugs increasing the risk of Fibrinolytics associated Bleeding include…
o Anticoagulants (Warfarin, Heparin, Enoxaparin, Dabigatran, etc)
o Antiplatelet agents (Aspirin, Clopidogrel, etc)
o Pentosan Polysulfate Sodium
• Herbs increasing the risk of Fibrinolytics associated Bleeding include…
o Fenugreek
o Garlic
o Ginkgo
o Evening Primrose Oil
o Clove Oil
o Anise
o Turmeric (Curcumin)
o Licorice
o Asafetida
o Capsicum (Capsaicin)
o Celery
o Kava
o Cat's claw
o Medowsweet
o Feverfew
o Tan-shen
• It is Contraindicated to use Fibrinolytics and Defibrotide concomitantly.
• Drugs increasing the risk of Fibrinolytics associated Bleeding include…
o Anticoagulants (Warfarin, Heparin, Enoxaparin, Dabigatran, etc)
o Antiplatelet agents (Aspirin, Clopidogrel, etc)
o Pentosan Polysulfate Sodium
• Herbs increasing the risk of Fibrinolytics associated Bleeding include…
o Fenugreek
o Garlic
o Ginkgo
o Evening Primrose Oil
o Clove Oil
o Anise
o Turmeric (Curcumin)
o Licorice
o Asafetida
o Capsicum (Capsaicin)
o Celery
o Kava
o Cat's claw
o Medowsweet
o Feverfew
o Tan-shen
• Concurrent use of Streptokinase and Antiplatelet agents such as Aspirin, Dipyridamole and Clopidogrel results in elevated risk of Bleeding.
• It is Contraindicated to use Fibrinolytics and Defibrotide concomitantly.
• Drugs increasing the risk of Fibrinolytics associated Bleeding include…
o Anticoagulants (Warfarin, Heparin, Enoxaparin, Dabigatran, etc)
o Antiplatelet agents (Aspirin, Clopidogrel, etc)
o Pentosan Polysulfate Sodium
• Herbs increasing the risk of Fibrinolytics associated Bleeding include…
o Fenugreek
o Garlic
o Ginkgo
o Evening Primrose Oil
o Clove Oil
o Anise
o Turmeric (Curcumin)
o Licorice
o Asafetida
o Capsicum (Capsaicin)
o Celery
o Kava
o Cat's claw
o Medowsweet
o Feverfew
o Tan-shen
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Naina Mohamed, PhD
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA):
• The risk of Orolingual Angioedema is increased by the concomitant use of Alteplase and ACE inhibitors (Captopril, Lisinopril, Perindopril, etc).
• Concurrent use of Alteplase and Nitroglycerin (GTN) results in Less coronary artery reperfusion, Longer time to reperfusion, and more coronary artery Reocclusion
• It is Contraindicated to use Fibrinolytics and Defibrotide concomitantly.
• Drugs increasing the risk of Fibrinolytics associated Bleeding include…
o Anticoagulants (Warfarin, Heparin, Enoxaparin, Dabigatran, etc)
o Antiplatelet agents (Aspirin, Clopidogrel, etc)
o Pentosan Polysulfate Sodium
• Herbs increasing the risk of Fibrinolytics associated Bleeding include…
o Fenugreek
o Garlic
o Ginkgo
o Evening Primrose Oil
o Clove Oil
o Anise
o Turmeric (Curcumin)
o Licorice
o Asafetida
o Capsicum (Capsaicin)
o Celery
o Kava
o Cat's claw
o Medowsweet
o Feverfew
o Tan-shen
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Naina Mohamed, PhD
The document discusses clinically important drug interactions of various anticoagulants including warfarin, dabigatran, heparin, with other medications, supplements, foods and diseases. It provides details of potential mechanisms of interactions that can increase bleeding risk like additive anticoagulant or antiplatelet effects, or decrease anticoagulant effectiveness by affecting drug metabolism. Close monitoring of anticoagulant effect and bleeding signs are recommended when using certain interacting agents together due to the risk of bleeding complications or reduced thrombosis prevention.
• Concomitant use of Dabigatran and Itraconazole or Ketoconazole is contraindicated.
• Drugs such as Heparin, Enoxaparin, Dalteparin, Tinzaparin, Bivalirudin, Lepirudin, Fondaparinux, Phenindione, Danaparoid, Rivaroxaban, Apixaban, Verapamil, Quinidine, Amiodarone, Ketoconazole, Itraconazole, Ritonavir, Saquinavir, Nelfinavir, Tacrolimus and Cyclosporine increase the risk of Dabigatran induced bleeding.
• Coadministration of Dabigatran with P-Glycoprotein Inducers like Carbamazepine, Rifampin or St. John's wort elevate the risk of Thrombosis.
The document discusses drug interactions of the anticoagulant argatroban. It notes that argatroban can interact with other anticoagulants, antiplatelets, NSAIDs, SSRIs, SNRIs, St. John's Wort, herbal supplements like ginkgo and garlic, and foods like papaya - increasing the risk of bleeding. It advises close monitoring when argatroban is taken with these substances. The document also provides tips for patients taking anticoagulants and references additional sources on drug interactions.
Hirudins such as Bivalirudin, Desirudin, Lepirudin can interact majorly with drugs such as Warfarin, Heparin, Enoxaparin, Dalteparin, Tinzaparin, Fondaparinux, Phenindione, Argatroban, Rivaroxaban, Apixaban and Dabigatran.
Danaparoid can interact majorly with drugs such as Warfarin, Hirudins (Bivalirudin, Lepirudin) and Other Anticoagulants like Heparin, Enoxaparin, Dalteparin, Tinzaparin, Fondaparinux, Phenindione, Argatroban, Rivaroxaban, Apixaban and Dabigatran.
Drug interactions of Low Molecular weight Heparins (LMWHs)Naina Mohamed, PhD
This document discusses drug interactions of low molecular weight heparins (LMWHs), which are a class of anticoagulants. It notes that LMWHs can interact with various prescription drugs, supplements, foods and herbs to increase the risk of bleeding. Specifically, it finds that LMWHs combined with warfarin, heparin, other anticoagulants, antiplatelet agents, fibrinolytics, NSAIDs, SSRIs, SNRIs, St. John's Wort, ginkgo, garlic, papaya, chamomile and various other supplements can have additive anticoagulant effects and increase bleeding risk. It advises close monitoring of patients if these drugs are coadmin
Concomitant use of Heparin and Telavancin or Oritavancin is contraindicated. Heparin may also interact majorly with other Anticoagulants such as Enoxaparin, Dalteparin, Bivalirudin, Danaparoid, Rivaroxaban, Apixaban and Dabigatran.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
2. Introduction
• Most smokers today know that smoking is bad for
their health and harmful to people around them.
• The smokers might have tried to quit in the past and
failed due to addiction.
• The Public Health Service (PHS) and the Agency for
Healthcare Research and Quality (AHRQ)
guidelines for treating tobacco use and
dependence, recommends…
o Brief clinical interventions
o Pharmacotherapy
3. Brief clinical interventions
•
•
•
The Public Health Service (PHS) and the Agency for Healthcare
Research and Quality (AHRQ) recommend that health care workers
screen all patients for tobacco use and provide advice and followup behavioral treatments to all tobacco users.
The PHS guidelines emphasize on use of the 5 A's in clinical settings:
o Ask about tobacco use,
o Advise to quit,
o Assess willingness to make a quit attempt,
o Assist in quit attempt, and
o Arrange for follow-up.
The American Academy of Family Physicians has attempted to
simplify this to 2 A's:
o Ask about tobacco use and
o Act to advise smoker to quit, assess interest in a quitting, assisting
in organizing pharmacotherapy and arranging for follow-up.
4. Nicotine Dependence
Tobacco smoke
Nicotine
Binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic
pathways
Opening of sodium, calcium, and potassium channels
Depolarization
Activation of voltage-gated calcium channels
More calcium to enter the axon terminal
Release of Dopamine into the synapse
Euphoric and addictive properties of nicotine
5. Nicotine actions
Nicotine
Binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal
medulla
Opening of Na+ ion channel
Influx of sodium
Depolarization of the cell
Activation of voltage-gated calcium channels
Calcium triggers the release of Epinephrine from intracellular vesicles into the
bloodstream
Vasoconstriction, increased blood pressure, increased heart rate, and increased
blood sugar
6. Pharmacotherapy
•
•
•
•
•
•
Nicotine is the psychoactive drug in tobacco products which produces
physical addiction.
Research suggests that nicotine may be as addictive as heroin, cocaine, or
alcohol.
Quitting smoking is difficult and may require multiple attempts.
Users often relapse because of stress, weight gain, and withdrawal symptoms.
Nicotine withdrawal symptoms may include irritability, anxiety, difficulty
concentrating, and increased appetite.
Nicotine dependence may be treated by the following…
o Nicotine replacement Therapy (NRT)
o Over-the-counter (e.g., nicotine patch, gum, lozenge)
o Prescription (e.g., nicotine inhaler, nasal spray)
o Non-nicotine Prescription medications
o Bupropion SR (Zyban®)
o Varenicline tartrate (Chantix®)
7. Nicotine replacement Therapy
•
•
•
•
•
•
•
Nicotine has both stimulant and depressant actions.
Research has shown that using nicotine replacement therapy (NRT)
can reduce the number of cigarettes smoked and cut down the
amount of dangerous inhaled smoke which contains harmful
Polycyclic aromatic hydrocarbons (PAHs) responsible for most of
harmful health effects.
Patients should be counseled to stop smoking completely prior to
initiating NRT to avoid the potential risk of nicotine overdose.
Using two forms of nicotine replacement (eg, patch plus resin) results
in higher quit rates and should be recommended if other forms of
nicotine replacement are not effective alone.
use of NRT is recommended for a minimum of 6-8 weeks.
Quit rates with use of NRT range between 20% and 24%.
Side effects of NRT mainly include local irritation (ie, mouth sores, skin
rash, nasal and throat irritation) associated with the route of
administration of the medication (ie, mouth, skin, nares).
8. Mechanism of action of NRT
Nicotine replacement Therapy (NRT)
Smaller amounts of Nicotine
Bind to nicotinic acetylcholine receptors
Release of Dopamine
Reduced cravings for cigarettes & other tobacco products
NRT products still contain nicotine, which is harmful and addictive, but they
deliver smaller amounts than cigarettes and without any of the other harmful
substances in tobacco, such as tar and carbon monoxide.
9. Bupropion
•
•
•
•
•
•
Bupropion (Zyban) is an antidepressant medicine and can be
used to relieve the symptoms of nicotine withdrawal in
quitters.
Bupropion reduces the desire to smoke and has a similar
success rate to NRT.
Sustained-release bupropion is started at a dose of 150 mg
daily for 3 days before increasing to 150 mg twice daily on
day 4.
Treatment with bupropion is begun 1-2 weeks before the
anticipated quit date.
The standard treatment course of bupropion (Zyban) in 8
weeks yields quit rates of about 30%.
Bupropion is contraindicated among patients with a history of
seizure disorder, current substance abuse, or other conditions
that may lower the seizure threshold.
10. Mechanism of action of Bupropion
Bupropion
Relatively weak inhibitor of the neuronal reuptake of norepinephrine
and dopamine
Interruption of areas of the brain that are associated with addiction and
the pleasurable effects of nicotine
Reduction of the desire to smoke and dampens the physical symptoms
of nicotine withdrawal
Bupropion (Zyban) is an alternative to NRT and doesn't contain
nicotine.
Bupropion (Zyban) may cause side effects such as fever, nausea,
agitation, anxiety, dry mouth, headache, skin rashes and constipation. It
can also intensify the sleep problems that many people encounter when
they stop smoking.
Bupropion (Zyban) should not be used by people with epilepsy, liver
problems or with eating disorders such as bulimia and anorexia.
11. Varenicline
•
•
•
•
•
Varenicline (Chantix) is started 1 week prior to the identified
quit date, titrating up from a dose of 0.5 mg daily for 3 days,
to 0.5 mg twice daily for days 4-7, then to 1 mg twice day
beginning on day 8.
Rates of continuous abstinence are 44%.
It takes about 12 weeks for the nicotine receptors in the brain
to switch off (or 'down-regulate') after cessation. Hence,
varenicline is usually prescribed for 12 weeks.
Those who are abstinent at 12 weeks may continue with
another 12 weeks of treatment.
Varenicline (Chantix) is an alternative to NRT and doesn't
contain nicotine.
12. Mechanism of action of Varenicline
Varenicline
Partial agonist of α4β2 nicotinic Ach Receptor
Agonistic activity stimulates moderate levels of dopamine in the terminal synapse in the
nucleus accumbens & antagonistic property competitively inhibits nicotine at the α 4β2
receptor
Reduction of nicotine craving and withdrawal symptoms
varenicline alleviates the symptoms of nicotine craving and withdrawal through its agonist
activity while inhibiting the effects of repeated nicotine exposure by its antagonist activity.
The most commonly encountered side effects are nausea, insomnia, and abnormal
dreams.
Other common side effects include headache, difficulty sleeping, abnormal dreams,
increased appetite, taste changes, dry mouth, drowsiness, tiredness, dizziness, and gut
disturbances such as constipation, diarrhoea or indigestion.
Varenicline can double the chances of successfully quitting.
13. Tips to quit smoking
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Hide the matches, lighters, and ashtrays.
Designate the home a non-smoking area.
Ask people not to smoke around you.
Drink fewer caffeinated beverages which may stimulate the urge to smoke.
Avoid alcohol which may also increase the urge to smoke.
Change the habits connected with smoking.
Keep mints or gum (preferably sugarless) on hand to suppress urge to smoke.
Stay active to keep the mind off smoking and help relieve tension.
Take a walk, exercise, read a book, brush your teeth, take a shower, take a deep
breath or try a new a hobby.
Make a list of reasons why you want to quit.
Carry this with you at all times. When you have an urge for a cigarette, read your
list and it will help strengthen your resolve.
Look for support from others. Join a support group or smoking cessation program.
Do not go places where many people are smoking such as bars or clubs, and
smoking sections of restaurants.
Find someone who can support you, for example a family member, friend or
doctor.
14. •
•
•
•
•
FIRST – make your final decision to quit smoking
SECOND – choose the day (“Quit Smoking Day”) when you start
quitting smoking
THIRD – choose the method which will help you to quit smoking
FOURTH - learn how to deal with smoking withdrawal symptoms
FIFTH – maintenance stage – just keep your “quit smoking”
programme.
15. Complementary Health Approaches
for Smoking Cessation
•
•
•
Meditation:
o Meditation is a mind-body practice which cultivates abilities to maintain focused and clear
attention, and develop increased awareness of the present.
o To date, there have been a few randomized studies on mindfulness-based interventions for
smoking cessation, but there is not enough evidence.
o Meditation is considered to be safe for healthy people.
Hypnotherapy:
o Hypnosis (also called hypnotherapy) has been studied for a number of conditions, including state
anxiety (e.g., before medical procedures or surgeries), headaches, smoking cessation, pain
control, hot flashes in breast cancer survivors, and irritable bowel syndrome.
o
Many studies have investigated the effects of hypnotherapy on smoking cessation.
o
Hypnosis is considered safe when performed by a health professional trained in hypnotherapy.
o
Self-hypnosis also appears to be safe for most people.
o
There are no reported cases of injury resulting from self-hypnosis.
Yoga:
o Yoga is a mind and body practice with origins in ancient Indian philosophy.
o The various styles of yoga typically combine physical postures, breathing techniques, and
meditation or relaxation.
o
Only a few studies have been conducted on yoga for smoking cessation.
o
Yoga is generally low-impact and safe for healthy people when practiced appropriately under
the guidance of a well-trained instructor.
16. Complementary Health Approaches
for Smoking Cessation (Contd)
•
•
Acupuncture:
o The term “acupuncture” describes a family of procedures
involving the stimulation of points on the body using a variety of
techniques.
o Several studies have been conducted on the effects of
acupuncture or acupressure for smoking cessation.
o When not delivered properly, acupuncture can cause serious
adverse effects, including infections and punctured organs.
Tai Chi:
o Tai chi, which originated in China as a martial art, is sometimes
referred to as “moving meditation"—practitioners move their
bodies slowly, gently, and with awareness, while breathing
deeply.
o To date, only a few studies have examined the effects of tai chi
for smoking cessation.
o Tai chi is a relatively safe practice for most people.
17.
18. •
•
•
•
•
•
•
References
CURRENT Diagnosis & Treatment in Family Medicine, 3e
Jeannette E. South-Paul, Samuel C. Matheny, Evelyn L. Lewis
Harrison's Online
Featuring the complete contents of Harrison's Principles of
Internal Medicine, 18e
Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J.
Larry Jameson, Joseph Loscalzo, Eds.
Behavioral Medicine: A Guide for Clinical Practice, 3e
Mitchell D. Feldman, John F. Christensen
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e
Laurence L. Brunton, Bruce A. Chabner, Björn C. Knollmann
Hurst's The Heart, 13e
Valentin Fuster, Richard A. Walsh, Robert A. Harrington
The MD Anderson Manual of Medical Oncology, 2e
Hagop M. Kantarjian, Robert A. Wolff, Charles A Koller
CURRENT Diagnosis & Treatment in Pulmonary Medicine
Michael E. Hanley and Carolyn H. Welsh